𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Diabetes is not a risk factor for tardive dyskinesia: a retrospective observational study

✍ Scribed by Michele Raja; Antonella Azzoni


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
46 KB
Volume
17
Category
Article
ISSN
0885-6222

No coin nor oath required. For personal study only.

✦ Synopsis


The aim of this observational study was to compare the prevalence of tardive dyskinesia (TD) in diabetic and non diabetic patients. We compared 34 diabetic patients with 34 non diabetic controls, matched by sex, age and time of admission, who had received a complete neuropsychiatric evaluation and who had been exposed to antidopaminergic treatment for at least 3 months. Among them, 8 of 24 diabetic (33.3%) and 6 of 15 (40.0%) non diabetic patients presented TD. The prevalence of TD in the diabetic group is numerically lower than in the controls but the difference is not statistically significant (chi(2) = 0.006; fd = 1; p = 0.937). These results suggest that diabetes is unlikely to play a major role in the pathogenesis of TD.


πŸ“œ SIMILAR VOLUMES


Non-therapeutic risk factors for onset o
✍ Diederik E. Tenback; Peter N. van Harten; Jim van Os πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 92 KB

## Abstract A meta‐analysis of prospective studies with schizophrenia patients was conducted to examine whether the evidence exists for risk factors for the emergence of Tardive Dyskinesia (TD) in schizophrenia. A computer assisted Medline/PubMed and Embase search was conducted in January 2008 for

Low educational status is a risk factor
✍ Nilsson, P.M.; Johansson, S.-E.; Sundquist, J. πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 69 KB πŸ‘ 1 views

Diabetes mellitus and its complications are an important cause of mortality in Western populations. The purpose of the present study was to examine the relationship between self-reported diabetes mellitus, gender, attained level of education, and socio-economic resources to all-cause mortality risk

CHEK2 1100delC is not a risk factor for
✍ Kirsi SyrjΓ€koski; Tuula KuukasjΓ€rvi; Anssi Auvinen; Olli-P Kallioniemi πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 50 KB

## Abstract Genetic risk factors for male breast cancer (MBC) are poorly understood. High penetrance genes such as BRCA1 or BRCA2 account for only a small proportion of the disease. A 1100delC mutation in CHEK2 (previously known as CHK2), a cell‐cycle checkpoint kinase, has been implicated in predi